Max Robotics — Global Service Robot Directory + US Certification

About

Dr. Juliette Thariat is a leading radiation oncologist whose research focuses on integrating advanced stereotactic and robotic technologies into cancer treatment, particularly for breast and head and neck cancers. Her major contributions include pioneering the use of robotic stereotactic radioablation alongside neoadjuvant chemotherapy for breast tumors, as detailed in her 2009 study (30 citations), and evaluating the early toxicity of CyberKnife® treatments for lung cancers (17 citations). She has also driven significant progress in head and neck oncology, examining the impact of surgical advances on postoperative radiotherapy and refining the management of cervical lymph node metastases from unknown primary cancers. Notably, Dr. Thariat is the principal investigator of the RoboCUP trial (2025), a randomized phase 2 study exploring transoral robotic surgery and laser microsurgery to identify occult head and neck primaries, aiming to reduce radiotherapy volumes and patient morbidity. Her work, spanning from early feasibility studies to ongoing clinical trials, has garnered over 60 citations, underscoring her influence in shaping more precise, less toxic cancer therapies. Dr. Thariat’s dedication to integrating robotics and stereotactic techniques continues to advance personalized treatment paradigms.